Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States

At rare, extremely high blood glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading.

April 15, 2013

Abbott Park, Illinois (NYSE: ABT) — Abbott today announced it is initiating a voluntary recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States. The company has determined that at extremely high blood glucose levels of 1024 mg/dL and above, the FreeStyle InsuLinx Meter will display and store in memory an incorrect test result that is 1024 mg/dL below the measured result. For example, at a blood glucose value of 1066 mg/dL, the meter will display and store a value of 42 mg/dL (1066 mg/dL – 1024 mg/dL = 42 mg/dL). No other Abbott blood glucose meters are impacted by this issue.
 
Please visit the Abbott site to read further details on the press release.

AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.